Clinical Trial Update: Efficacy and Safety of Aliskiren/Ramipril/Amlodipine Compared With Ramipril/Amlodipine and Aliskiren/Amlodipine in Patients With Metabolic Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the efficacy and safety of three-drug combination aliskiren/ramipril/amlodipine versus two-drug combinations ramipril/amlodipine and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Metabolic Syndrome

Drugs mentioned

• Aliskiren (Aliskiren)
• Amlodipine (amlodipine)
• Ramipril (ramipril)

Snippet

Sponsor: Novartis | Conditions: Hypertension With Metabolic Syndrome | Phase 4 | Status: TERMINATED | Results posted: 2011-05-24